手機掃碼訪問本站
微信咨詢
猜你喜歡
- 5-氨基-2-甲基-1H-咪唑-4-甲酰胺 1.5HCL 1H2O
- (R)-Carisbamate
- 1-碘-2,3,4,5-四甲基苯,
- 6737-42-4 / Rh(II)/dppp共催化合成偕二硫化物
- 氧化鎵
- 117106-20-4 / N-Fmoc-N-甲基-O-叔丁基-L-蘇氨酸的制備
- 8-氯喹啉
- DL-乙硫氨酸
- 3-(N-丁基氨甲?；?-4-氟苯基硼酸
- 5805-57-2 / (1H-苯并咪唑-2-亞甲基)胺的制備
- CIS-3-(2,6-DIMETHYLBENZOYL)CYCLOPENTANE-1-CARBOXYLIC ACID
- -Oxo-3-pyridinebutyric Acid, N-Hydroxysuccinimide Ester
- 氯丙酰芐胺
- 4-methyl-5,6-dihydrofuro[2,3-d]pyrimidin-2-amine
- 雙苯鉻
- 4-CHLORO-3-HYDROXY-BENZOIC ACID ETHYL ESTER
- 甲烷磺酸(2-二環(huán)己基膦基-2′,6′-二甲氧基-1,1′-聯(lián)苯基)(2′-氨基-1,1′-聯(lián)苯-2-基)鈀(II) SPHOS PD G3
- 2-BROMO-1-(2,6-DIMETHOXYPHENYL)ETHANONE
- all-trans-Ethyl-β-ionylideacetate
- Hydrazine, (4-butylphenyl)- (9CI)
- 3-BROMO-2-(4-ISOCYANATOPHENYL)THIOPHENE
- 600-00-0 / 2-溴-2-甲基丙酸乙酯的制備方法
- 132907-72-3 / 鹽酸雷莫司瓊注射液的說明書
- N-METHYL-N-(4-PYRIDIN-2-YLBENZYL)AMINE
- 2，2′-聯(lián)萘酚
